Adenosine
|
Basic information |
| Metabolite name | Adenosine |
 | HMDB0000050 |
 |
C00212 |
 |
60961 |
| Synonyms | NA |
| No. of studies | 26 |
|
Basic information |
| Metabolite name | Adenosine |
| HMDB0000050 |
|
C00212 |
|
60961 |
| Synonyms | NA |
| No. of studies | 26 |
|
Relationship between Adenosine and depression (count: 26) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M062 | Type1 | CUMS group vs. control group | Cerebellum | Sprague-Dawley rat | Up |
| Study M071 | Type2 | CUMS + imipramine group vs. CUMS group | Hippocampus | C57BL/6N mouse | Down |
| Study M071 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | C57BL/6N mouse | Down |
| Study M073 | Type1 | depressed group vs. control group | Serum | Human | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA3 region of hippocampus | ICR mouse | Up |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Down |
| Study M116 | Type3 | ketamine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M119 | Type1 | LH group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M131 | Type1 | CRS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Down |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Down |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M663 | Type3 | diterpene ginkgolides group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M670 | Type2 | corticosterone + nicotinamide mononucleotide group vs. corticosterone group | Liver | C57/BL6 mouse | Up |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Thyroid | ICR mouse | Down |
| Study M712 | Type1 | depression group vs. control group | Prefrontal cortex | Cynomolgus monkey | Down |
| Study M839 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M847 | Type2 | CUMS + Bupleuri Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M882 | Type1 | CUMS group vs. control group | Jejunum | Sprague-Dawley rat | Down |
| Study M894 | Type2 | electromagnetic field exposure + heat acclimation group vs. electromagnetic field exposure group | Serum | C57BL/6J mouse | Down |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M957 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Down |